Altimmune Inc (ALT)

Cost of Revenue

$15.01M

TTM · Period ending: · USD

ALT logo

ALT Cost of Revenue

Latest reported$15.01M
ALT TTM Cost of Revenue ($0.00 → $15.01M)
High-resolution chart · PNG

ALT cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Altimmune Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
15,006,000
14,983,000
14,960,000
14,960,000
0
0
107,000
107,000
18,495,000
31,748,000
31,641,000
50,820,000
52,694,000
39,441,000
56,325,000
58,191,000
67,135,000
80,407,000
74,521,000
68,481,562
39,275,562
26,003,562
20,443,093
7,610,620
16,340,317
19,285,413
17,065,553
17,957,158
13,956,187
15,930,052
18,459,352
19,854,584
21,031,410
21,367,178
18,406,329
16,322,818
12,818,180
8,944,964
7,221,460
6,389,217
5,634,705
4,253,192
3,190,574
1,646,402
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.